GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: TP0586532 is a non-hydroxamate inhibitor of bacterial UDP-3-O-acyl-N-acetylglucosamine deacetylase (LpxC) [6]. LpxC is an attractive target for the development of antibacterial agents against Gram-negative bacterial pathogens, although safety and activity issues have so far precluded approval for clinical use of these drugs [1,3]. LpxC inhibitors that do not contain a hydroxamate moiety, such as TP0586532, are predicted to have a reduced risk of cardiovascular toxicity.
Note that the structure shown here matches the CAS-assigned structure. The PubChem link, provided in the table below, is to their standardized chemical structure (CID 155294517), although this is not an exact structural match. |
|
|||||||||||||||||||||||||||||||||||
| No information available. |
Mechanism Of Action and Pharmacodynamic Effects ![]() |
| The antibacterial MMOA is inhibition of LpxC [6], which is an essential enzyme in the biosynthesis of lipid A (also know as endotoxin), the hydrophobic anchor of lipopolysaccharide (LPS) and a major component of the outer membrane of Gram-negative bacteria [4-5]. |